Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

The association of Klippel-Trenaunay syndrome and abdominal aortic aneurysms.

Braet DJ, Khoukaz HB, Vogel TR, Tewari SO, Fay WP.

J Vasc Surg Cases Innov Tech. 2019 Jun 29;5(3):343-344. doi: 10.1016/j.jvscit.2019.04.001. eCollection 2019 Sep. No abstract available.

2.

Overproduction of endothelin-1 impairs glucose tolerance but does not promote visceral adipose tissue inflammation or limit metabolic adaptations to exercise.

Jurrissen TJ, Grunewald ZI, Woodford ML, Winn NC, Ball JR, Smith TN, Wheeler AA, Rawlings AL, Staveley-O'Carroll KF, Ji Y, Fay WP, Paradis P, Schiffrin EL, Vieira-Potter VJ, Fadel PJ, Martinez-Lemus LA, Padilla J.

Am J Physiol Endocrinol Metab. 2019 Sep 1;317(3):E548-E558. doi: 10.1152/ajpendo.00178.2019. Epub 2019 Jul 16.

PMID:
31310581
3.

No Sweetie Pie: Newly Uncovered Role for PAI (Plasminogen Activator Inhibitor)-1 in Inflammatory Responses to Ischemia/Reperfusion.

Fay WP, Korthuis RJ.

Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):695-697. doi: 10.1161/ATVBAHA.118.310824. No abstract available.

4.

Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin.

Luo M, Ji Y, Luo Y, Li R, Fay WP, Wu J.

J Thromb Haemost. 2017 Dec;15(12):2451-2460. doi: 10.1111/jth.13869. Epub 2017 Nov 8.

5.

Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization.

Ji Y, Adeola O, Strawn TL, Jeong SS, Chen R, Fay WP.

J Thromb Haemost. 2017 Apr;15(4):814-825. doi: 10.1111/jth.13621. Epub 2017 Feb 23.

6.

Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion-induced Myocardial Injury and Adverse Remodeling.

Erikson JM, Valente AJ, Mummidi S, Kandikattu HK, DeMarco VG, Bender SB, Fay WP, Siebenlist U, Chandrasekar B.

J Biol Chem. 2017 Feb 10;292(6):2345-2358. doi: 10.1074/jbc.M116.764522. Epub 2017 Jan 4.

7.

Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.

Ji Y, Weng Z, Fish P, Goyal N, Luo M, Myears SP, Strawn TL, Chandrasekar B, Wu J, Fay WP.

Arterioscler Thromb Vasc Biol. 2016 Nov;36(11):2167-2175. Epub 2016 Sep 22.

8.

Laminin Receptor-Avid Nanotherapeutic EGCg-AuNPs as a Potential Alternative Therapeutic Approach to Prevent Restenosis.

Khoobchandani M, Katti K, Maxwell A, Fay WP, Katti KV.

Int J Mol Sci. 2016 Mar 1;17(3):316. doi: 10.3390/ijms17030316.

9.

The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4.

Somanna NK, Valente AJ, Krenz M, Fay WP, Delafontaine P, Chandrasekar B.

J Cell Physiol. 2016 May;231(5):1130-41. doi: 10.1002/jcp.25210. Epub 2015 Oct 19.

10.

Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma.

Chen N, Ren M, Li R, Deng X, Li Y, Yan K, Xiao L, Yang Y, Wang L, Luo M, Fay WP, Wu J.

Mol Cancer. 2015 Jul 29;14:140. doi: 10.1186/s12943-015-0418-x.

11.

Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.

Wu J, Strawn TL, Luo M, Wang L, Li R, Ren M, Xia J, Zhang Z, Ma W, Luo T, Lawrence DA, Fay WP.

Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):111-20. doi: 10.1161/ATVBAHA.114.304554. Epub 2014 Nov 6.

12.

C-reactive protein induces expression of tissue factor and plasminogen activator inhibitor-1 and promotes fibrin accumulation in vein grafts.

Ji Y, Fish PM, Strawn TL, Lohman AW, Wu J, Szalai AJ, Fay WP.

J Thromb Haemost. 2014 Oct;12(10):1667-77. doi: 10.1111/jth.12680. Epub 2014 Aug 23.

13.

Acute isolated right ventricular myocardial infarction masquerading as acute anterior myocardial infarction.

Sidhu MS, Aggarwal K, Fay WP.

BMJ Case Rep. 2014 Feb 13;2014. pii: bcr2012008087. doi: 10.1136/bcr-2012-008087. No abstract available.

15.

Homocysteine and thrombosis: guilt by association?

Fay WP.

Blood. 2012 Mar 29;119(13):2977-8. doi: 10.1182/blood-2012-01-401513.

16.

Towards a standardization of the murine ferric chloride-induced carotid arterial thrombosis model.

Owens AP 3rd, Lu Y, Whinna HC, Gachet C, Fay WP, Mackman N.

J Thromb Haemost. 2011 Sep;9(9):1862-3. doi: 10.1111/j.1538-7836.2011.04287.x. No abstract available.

17.

Antecedent hydrogen sulfide elicits an anti-inflammatory phenotype in postischemic murine small intestine: role of heme oxygenase-1.

Zuidema MY, Peyton KJ, Fay WP, Durante W, Korthuis RJ.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H888-94. doi: 10.1152/ajpheart.00432.2010. Epub 2011 Jun 10.

18.

Thrombosis, physical activity, and acute coronary syndromes.

Kumar A, Kar S, Fay WP.

J Appl Physiol (1985). 2011 Aug;111(2):599-605. doi: 10.1152/japplphysiol.00017.2011. Epub 2011 May 19. Review.

19.

Intravital fluorescence microscopy improves thrombosis phenotype scoring in mice.

Fay WP.

Arterioscler Thromb Vasc Biol. 2011 Jun;31(6):1253-4. doi: 10.1161/ATVBAHA.111.226290. No abstract available.

PMID:
21593457
20.

Multifaceted role of plasminogen activator inhibitor-1 in regulating early remodeling of vein bypass grafts.

Ji Y, Strawn TL, Grunz EA, Stevenson MJ, Lohman AW, Lawrence DA, Fay WP.

Arterioscler Thromb Vasc Biol. 2011 Aug;31(8):1781-7. doi: 10.1161/ATVBAHA.111.228767. Epub 2011 May 12.

Supplemental Content

Support Center